A breakthrough technology

M-TRAP® Technology is based on the detection of antigen-antibody interaction on a porous membrane. Only the red blood cells having the corresponding antigen are fixed into the membrane revealing immediately the reaction.

The principle:

The M-TRAP® Technology, patented by DIAGAST, relies on the superposition of membranes and has 2 major advantages:

  1. Since the test antibodies are inside the upper membrane, they never get in direct contact with the user. There is no risk of cross-contamination.
  2. Since the lower membrane absorbs the liquids of the test (PAD Buffer and sample), the risk of blood exposure is considerably lower.

This simple protocol takes place in 3 steps and in 30 seconds.

A very broad field of use:

Easy implementation, easy user-friend, easy reading!
The M-TRAP® technology has all the assets for optimal results in all conditions, however extreme they may be. See the vidéos under.

Product protocole for hospitals

Patient bedside
Blood group control of blood bags

  • Pre filled/ coated monoclonal reagents
  • No risk of cross-contamination between the reagents
  • Use of blood bag segments, patients finger, EDTA/CPD/Heparin tubes
  • Clear and colorimetric reactions
  • Traceability: results can be saved
Product protocole for Blood Banks

Pre-screening of donors
Blood group control of blood bags

  • 150 tests / hour*
  • Storage up to 25 °C
  • Use of multichannel pipettes
  • Less repetitive gestures
  • Standardized workstation
Product protocol for outside labs

Blood donation camps

  • Portable PAD®: no need of electric power or any equipment, usable in remote areas
  • 2 devices used: the PAD® and the PAD® Buffer
  • Usable up to 40 °C

Associated products:

ABD PAD® – 10×20 tests (200 tests) 40102 Technical insert
PAD Buffer 40100 Technical insert
PAD Buffer 500 40104 Technical insert
Acti-Lance Lice 28 G – 1000 pcs 118814
Pipettes – 3200 pcs 119421
Zip bags – 500 pcs (for transport and storage after use) 119422